Home › NDC Lookup › RxCUI directory › RxCUI 1190738

Atropine sulfate 0.025 MG / difenoxin hydrochloride 1 MG Oral Tablet — RxCUI 1190738

Name: Atropine sulfate 0.025 MG / difenoxin hydrochloride 1 MG Oral Tablet (RxCUI 1190738)
Creator: Brian Staiger, PharmD

RxNorm drug concept · Semantic clinical drug

RxCUI 1190738 Semantic clinical drug · SCD ● Current RxNorm concept 2 FDA products 2 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by Dr. Brian Staiger, PharmD

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1190738

Official nameAtropine sulfate 0.025 MG / difenoxin hydrochloride 1 MG Oral Tablet

Concept typeSemantic clinical drug (SCD)

RxNorm statusCurrent RxNorm concept

Also known asdifenoxin 1 MG / atropine sulfate 0.025 MG Oral Tablet

FDA products mapped2

Package NDCs mapped2

RxNorm release07/06/2026

Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Atropine Ophthalmic: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist

That's completely expected with atropine — it's actually doing its job. The drop temporarily shuts down the muscle that controls your pupil and your eye's ability to focus, and tho...
Why does my vision stay blurry and my eyes stay sensitive to light for so long after using these drops?
Good question! When one eye is significantly stronger than the other, the brain tends to ignore the weaker eye. Putting an atropine drop in the stronger eye blurs it on purpose, so...
My child's doctor prescribed these drops for lazy eye — how does that work?

📖 Read our full Atropine Ophthalmic guide →

🕸️ Concept Web — How Atropine sulfate 0.025 MG / difenoxin hydrochlor... Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.

This page's concept Atropine sulfate 0.025 MG / difenoxin hydrochloride 1 MG Oral Tablet RxCUI 1190738 Semantic clinical drug · SCD

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

Ingredients 5

The active substance itself — no strength, form, or brand attached yet.
- Atropine 1223 IN
- Difenoxin 23024 IN
- Atropine / difenoxin 214261 MIN
- Atropine sulfate 153971 PIN
- Difenoxin hydrochloride 235373 PIN
Brand names 1

The same medicine's trade names. A brand name alone says nothing about strength or form.
- Motofen 218445 BN
Dose forms 13

The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.
- Atropine / difenoxin Oral Tablet 371827 SCDF
- Atropine sulfate / difenoxin hydrochloride Oral Tablet 2648141 SCDFP
- Atropine / difenoxin Oral Product 1154982 SCDG
- Atropine / difenoxin Pill 1154983 SCDG
- Atropine sulfate / difenoxin hydrochloride Oral Product 2660587 SCDGP
- Atropine sulfate / difenoxin hydrochloride Pill 2659098 SCDGP
- Atropine / difenoxin Oral Tablet [Motofen] 369383 SBDF
- Atropine sulfate / difenoxin hydrochloride Oral Tablet [Motofen] 2656463 SBDFP
- +5 more in this family
Clinical & branded drugs 4

Ingredient + strength + dose form. These are the concepts real FDA products actually carry.
- Atropine sulfate 0.025 MG 1048082 SCDC
- Difenoxin hydrochloride 1 MG 1190737 SCDC
- Atropine sulfate 0.025 MG / difenoxin hydrochloride 1 MG Oral Tablet [Motofen] 1190740 SBD
- Atropine sulfate 0.025 MG / difenoxin hydrochloride 1 MG [Motofen] 1190739 SBDC

Showing up to 8 concepts per family — 18 of 23 stored related concepts drawn.

These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

Atropine sulfate 0.025 MG SCDC · 1048082
Difenoxin hydrochloride 1 MG SCDC · 1190737
Atropine / difenoxin Oral Tablet SCDF · 371827
Atropine sulfate / difenoxin hydrochloride Oral Tablet SCDFP · 2648141
Atropine / difenoxin Oral Product SCDG · 1154982
Atropine / difenoxin Pill SCDG · 1154983
Atropine sulfate / difenoxin hydrochloride Oral Product SCDGP · 2660587
Atropine sulfate / difenoxin hydrochloride Pill SCDGP · 2659098

Brand-Name Concepts

Atropine sulfate 0.025 MG / difenoxin hydrochloride 1 MG Oral Tablet [Motofen] SBD · 1190740
Atropine sulfate 0.025 MG / difenoxin hydrochloride 1 MG [Motofen] SBDC · 1190739
Atropine / difenoxin Oral Tablet [Motofen] SBDF · 369383
Atropine sulfate / difenoxin hydrochloride Oral Tablet [Motofen] SBDFP · 2656463
Motofen Oral Product SBDG · 1182809
Motofen Pill SBDG · 1182810
Motofen BN · 218445

📦 FDA Products & Package NDCs

2 products · 2 package NDCs

2 package NDCs map to RxCUI 1190738 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.

Package NDC	Package	Brand / generic name	Labeler	Marketing start
54766-0200-10	100 TABLET in 1 BOTTLE (54766-200-10)	Motofen	Sebela Pharmaceuticals Inc.	2017-04-11
83107-0011-10	100 TABLET in 1 BOTTLE (83107-011-10)	Motofen	Legacy Pharma USA Inc.	2026-01-01

Observed labelers: Legacy Pharma USA Inc. (1) · Sebela Pharmaceuticals Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

💲 Pricing (NADAC)

NADAC is CMS's National Average Drug Acquisition Cost — roughly what pharmacies pay to buy the drug. It is an acquisition benchmark, not your copay.

Per ea · median

$6.9253

Range $6.9253–$6.9253 · middle 50% $6.9253–$6.9253 · 1 NDCs

Latest compatible distributions from the CMS NADAC file · dataset watermark 2026-07-10. Prices vary by package and pharmacy; a distribution is shown instead of one misleading number. Rows the dataset is silent on carry no price. No zero-cost conclusion should be drawn.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7

openFDA export observedJul 14, 2026

RxNorm release07/06/2026

Methodology2026-07-full-catalog-v1

A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.

This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.